Atreca, Inc. Made Headway

Thu, Oct 19, 2023 at 07:18 PM
Atreca, Inc. Made Headway

Atreca, Inc. (BCEL:NASDAQ) rocketted at $0.37, a gain of 35.9%. On Thu, Oct 19, 2023, BCEL:NASDAQ touched a New 2-Week Intraday High of $0.42. The stock appeared on our News Catalysts scanner on Thu, Sep 21, 2023 at 08:30 AM in the 'AGREEMENT' category. From Thu, Oct 05, 2023, the stock recorded 50.00% Up Days and 27.27% Green Days

The stock spiked on Thu, Oct 12, 2023 at $0.66 with a volume of 63M+.

About Atreca, Inc. (BCEL:NASDAQ)

Atreca Inc is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. The company's product candidate, ATRC-101, is a monoclonal antibody in preclinical development with a novel mechanism of action and target derived from an antibody identified using its discovery platform.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.